Latest Articles

  • Safety of statins: Effects on muscle and the liver
    Abu R. Vasudevan, MBBS, MD, MRCP, Yasmin S. Hamirani, MBBS and Peter H. Jones, MD
    Cleveland Clinic Journal of Medicine November 2005, 72 (11) 990-1001;

    Hepatotoxicity and myopathy are uncommon but worrisome. ALT and AST should be measured at baseline and periodically during statin therapy.

  • In reply: Pulmonary embolism imaging (SEPTEMBER 2005)
    Ruffin J. Graham, MD and Joseph W. Stengel, MD
    Cleveland Clinic Journal of Medicine November 2005, 72 (11) 1059;
  • A 39-year-old man with sudden onset of chest pain
    Prashanth R. Sunkureddi, MD, Emilio B. Gonzalez, MD, Rickey Washington, MD, Andres Salazar, MD and Paul Douglass, MD
    Cleveland Clinic Journal of Medicine November 2005, 72 (11) 1050-1056;

    He has a history of a transient ischemic attack and poorly controlled hypertension. What is the likely diagnosis?

  • A syringe in the hand is worth two birds in the bush
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine November 2005, 72 (11) 962;

    Short of a true pandemic, there is much we can do to make the 2005–2006 flu season a kinder, gentler one.

  • Anemia in chronic heart failure: Can EPO reduce deaths?
    Srinivas Iyengar, MD and William T. Abraham, MD
    Cleveland Clinic Journal of Medicine November 2005, 72 (11) 1027-1032;

    Many patients with chronic heart failure also have anemia, but whether treating the anemia will improve outcomes has yet to be determined.

  • What is a ‘failure’ of bisphosphonate therapy for osteoporosis?
    John J. Carey, MD
    Cleveland Clinic Journal of Medicine November 2005, 72 (11) 1033-1039;

    Assessing the effectiveness of bisphosphonate therapy is problematic. The true measure is prevention of new fractures.

  • Influenza 2005–2006
    Sherif B. Mossad, MD
    Cleveland Clinic Journal of Medicine November 2005, 72 (11) 1041-1047;

    Behind the preparation for the current influenza season are fears that the simmering outbreak of avian influenza in animals could lead to a pandemic in humans.

  • Hepatitis C infection: A systemic disease with extrahepatic manifestations
    Hepatitis C infection: A systemic disease with extrahepatic manifestations
    Aman Ali, MD and Nizar N. Zein, MD
    Cleveland Clinic Journal of Medicine November 2005, 72 (11) 1005-1019;

    Almost 40% of patients with hepatitis C develop at least one extrahepatic manifestation during the course of the disease.

  • Vascular disease: It’s not just the pipes
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine October 2005, 72 (10) 841;

    The management of patients with venous and arterial vascular disease keeps getting more complex.

  • Respiratory tract infections: Another reason not to smoke
    Susan Murin, MD, MSc and Kathryn Smith Bilello, MD
    Cleveland Clinic Journal of Medicine October 2005, 72 (10) 916-920;

    Patients who smoke need to be informed about the benefits of being vaccinated and stopping smoking.

Pages